MaxCyte Inc. Company Profile
NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MaxCyte at a glance
MaxCyte Inc. (NASDAQ: MXCT) is a Biotechnology: Commercial Physical & Biological Resarch company in the Health Care sector headquartered in Rockville, MD. MaxCyte is led by Mr. Maher Masoud and employs about 91 people. The company's shares have traded publicly since 2021.
At a market capitalization of $141.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001287098, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does MaxCyte do?
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Business description based on the company's public filings.
Company information
- Legal name
- MaxCyte Inc.
- Ticker
- NASDAQ: MXCT
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- CEO
- Mr. Maher Masoud
- Employees
- 91
- Headquarters
- 9713 Key West Avenue, Rockville, MD, United States
- Phone
- 301 944 1700
- Website
- maxcyte.com
- IPO year
- 2021
- Market cap
- $141.45M
- SEC CIK
- 0001287098
- Latest annual report
- 10-K · Mar 25, 2026
Companies similar to MaxCyte
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ONMDOneMedNet Corp Class A | 4.70 | +4.21% | $29.15M | vs MXCT |
| BIAFbioAffinity Technologies Inc. | 1.65 | -10.81% | $3.00M | vs MXCT |
| ISPCiSpecimen Inc. | 0.4563 | -13.58% | $2.64M | vs MXCT |
| NRCNRC Health | 25.16 | +0.68% | $533.93M | vs MXCT |
| OABIOmniAb Inc. | 4.66 | -7.36% | $679.71M | vs MXCT |
| ABSIAbsci Corporation | 7.51 | -7.97% | $1.30B | vs MXCT |
| ICLRICON plc | 186.71 | -1.92% | $13.99B | vs MXCT |
| CRLCharles River Laboratories International Inc. | 314.32 | -4.15% | $15.06B | vs MXCT |